Methylphenidate Hydrochloride Extended-release Tablets recall: Subpotent
Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC…
Why was Methylphenidate Hydrochloride Extended-release Tablets recalled?
Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lots: 170231B, 170232A, 170233A, 170234A
- Product
- Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC…
- Recalling firm
- Osmotica Pharmaceutical Corp
- Quantity
- 19,664 100-bottles
- Distribution
- Nationwide in the USA
- Recall date
- March 14, 2018
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)